SeaStar Medical (ICU) Competitors $0.59 -0.02 (-3.63%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.60 +0.01 (+0.91%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICU vs. ALUR, CLGN, NRXS, PSTV, NXL, IRIX, MHUA, XAIR, LYRA, and DHAIShould you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include Allurion Technologies (ALUR), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), Plus Therapeutics (PSTV), Nexalin Technology (NXL), IRIDEX (IRIX), Meihua International Medical Technologies (MHUA), Beyond Air (XAIR), Lyra Therapeutics (LYRA), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry. SeaStar Medical vs. Its Competitors Allurion Technologies CollPlant Biotechnologies NeurAxis Plus Therapeutics Nexalin Technology IRIDEX Meihua International Medical Technologies Beyond Air Lyra Therapeutics DIH Holding US SeaStar Medical (NASDAQ:ICU) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk. Do analysts recommend ICU or ALUR? Allurion Technologies has a consensus target price of $22.83, indicating a potential upside of 703.99%. Given Allurion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Allurion Technologies is more favorable than SeaStar Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media prefer ICU or ALUR? In the previous week, SeaStar Medical had 1 more articles in the media than Allurion Technologies. MarketBeat recorded 7 mentions for SeaStar Medical and 6 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of 0.45 beat SeaStar Medical's score of -0.01 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Allurion Technologies 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders have more ownership in ICU or ALUR? 1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 1.3% of SeaStar Medical shares are owned by insiders. Comparatively, 22.4% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, ICU or ALUR? SeaStar Medical has higher earnings, but lower revenue than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeaStar Medical$140K47.33-$24.83M-$3.47-0.17Allurion Technologies$32.11M0.66-$26.15M-$12.50-0.23 Which has more risk and volatility, ICU or ALUR? SeaStar Medical has a beta of -1.09, suggesting that its share price is 209% less volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.47, suggesting that its share price is 147% less volatile than the S&P 500. Is ICU or ALUR more profitable? SeaStar Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%. Company Net Margins Return on Equity Return on Assets SeaStar MedicalN/A N/A -313.28% Allurion Technologies -86.05%N/A -41.49% SummaryAllurion Technologies beats SeaStar Medical on 10 of the 16 factors compared between the two stocks. Get SeaStar Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICU vs. The Competition Export to ExcelMetricSeaStar MedicalMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.88M$7.37B$5.62B$9.10BDividend YieldN/A2.81%5.24%4.00%P/E Ratio-0.1733.8228.1020.27Price / Sales47.3335.57429.7099.23Price / CashN/A23.3737.4658.16Price / Book-1.746.858.045.49Net Income-$24.83M$233.05M$3.18B$250.45M7 Day Performance9.96%0.01%3.61%4.77%1 Month Performance-52.29%0.25%4.04%7.67%1 Year Performance-93.12%33.80%29.99%16.38% SeaStar Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICUSeaStar Medical0.3414 of 5 stars$0.59-3.6%N/A-92.3%$6.88M$140K-0.172Gap UpALURAllurion Technologies3.3049 of 5 stars$2.46+1.2%$22.83+828.2%-89.1%$18.12M$32.11M-0.20501News CoverageCLGNCollPlant Biotechnologies2.9539 of 5 stars$1.36-1.4%$11.50+745.6%-71.2%$17.55M$2.47M-1.1170News CoverageUpcoming EarningsNRXSNeurAxis3.3326 of 5 stars$2.42-2.4%$7.00+189.3%-14.0%$17.46M$2.93M-1.3219PSTVPlus Therapeutics1.6273 of 5 stars$0.35+10.4%$10.83+3,014.8%-80.5%$16.07MN/A-0.1220High Trading VolumeNXLNexalin Technology3.0217 of 5 stars$0.99+7.4%$5.00+406.2%-28.4%$15.80M$170K-1.193Positive NewsIRIXIRIDEX1.0838 of 5 stars$0.88+0.2%N/A-51.4%$14.77M$48.67M-2.05120Gap UpMHUAMeihua International Medical Technologies1.2453 of 5 stars$0.40-11.2%N/A-49.5%$14.36M$96.90M0.00620Positive NewsXAIRBeyond Air4.5195 of 5 stars$0.17+7.7%$1.50+770.6%-71.1%$13.82M$3.71M-0.2270News CoveragePositive NewsGap DownLYRALyra Therapeutics2.3944 of 5 stars$8.96-1.6%$100.00+1,016.1%-40.8%$12.07M$1.53M-0.1550DHAIDIH Holding US0.6684 of 5 stars$0.24-2.4%N/A-92.2%$11.88M$64.47M-0.82N/APositive News Related Companies and Tools Related Companies ALUR Alternatives CLGN Alternatives NRXS Alternatives PSTV Alternatives NXL Alternatives IRIX Alternatives MHUA Alternatives XAIR Alternatives LYRA Alternatives DHAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICU) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share SeaStar Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
